Fit performance status (ECOG 0-1): patient is fully active or restricted in physically st...
Детермінований перегляд YAML-сутності з джерельної бази. Клінічний авторитет лишається за вказаними source ID та статусом клінічного sign-off.
| ID | RF-FITNESS-ECOG-FIT |
|---|---|
| Тип | Тривожна ознака |
| Статус | переглянуто 2026-04-27 | очікує клінічного підпису |
| Хвороби | Не вказано |
| Джерела | SRC-ESMO-DLBCL-2024 SRC-NCCN-BCELL-2025 |
Походження тривожної ознаки
| Визначення | Fit performance status (ECOG 0-1): patient is fully active or restricted in physically strenuous activity but ambulatory and able to carry out light work. Eligible for full-dose chemotherapy and intensive regimens (CHOEP, BEACOPP-escalated, HD-MTX, ASCT consolidation, CAR-T). |
|---|---|
| Клінічний напрям | intensify |
| Категорія | fitness-eligibility |
Логіка спрацьовування
{
"any_of": [
{
"comparator": "<=",
"finding": "ecog",
"threshold": 1
}
],
"type": "composite_score"
}
Нотатки
Pan-disease eligibility gate. ECOG 0-1 is the canonical entry criterion for intensified regimens across DLBCL (CHOEP-21 in age ≤60 with elevated LDH per German High-Grade NHL Study Group), Hodgkin (BEACOPP-escalated), Burkitt (CODOX-M/IVAC, DA-EPOCH-R), CAR-T eligibility. Used in conjunction with organ-function gates. Conflict-resolution: when ECOG-FIT fires alongside RF-ORGAN-* de-escalation, organ-dysfunction wins (de-escalation has higher severity). Replaces free-text "ecog 0-1" all_of clauses across algorithms.
Де використовується
Algorithms
ALGO-CERVICAL-LOCALLY-ADVANCED-1L- ALGO-CERVICAL-LOCALLY-ADVANCED-1LALGO-CLL-1L- ALGO-CLL-1LALGO-DLBCL-1L- ALGO-DLBCL-1LALGO-DLBCL-2L- ALGO-DLBCL-2LALGO-ENDOMETRIAL-2L- ALGO-ENDOMETRIAL-2LALGO-ESOPH-2L- ALGO-ESOPH-2LALGO-ESOPH-RESECTABLE-1L- ALGO-ESOPH-RESECTABLE-1LALGO-FL-2L- ALGO-FL-2LALGO-GASTRIC-2L- ALGO-GASTRIC-2LALGO-GASTRIC-RESECTABLE-PERIOP- ALGO-GASTRIC-RESECTABLE-PERIOPALGO-GBM-NEWLY-DIAGNOSED-1L- ALGO-GBM-NEWLY-DIAGNOSED-1LALGO-GBM-RECURRENT- ALGO-GBM-RECURRENTALGO-GI-NET-ADVANCED-1L- ALGO-GI-NET-ADVANCED-1LALGO-HCC-SYSTEMIC-1L- ALGO-HCC-SYSTEMIC-1LALGO-HCC-SYSTEMIC-2L- ALGO-HCC-SYSTEMIC-2LALGO-HGBL-DH-2L- ALGO-HGBL-DH-2LALGO-HSTCL-1L- ALGO-HSTCL-1LALGO-MCL-2L- ALGO-MCL-2LALGO-MESOTHELIOMA-1L- ALGO-MESOTHELIOMA-1LALGO-MESOTHELIOMA-2L- ALGO-MESOTHELIOMA-2LALGO-MM-1L- ALGO-MM-1LALGO-MM-2L- ALGO-MM-2LALGO-MM-3L- ALGO-MM-3LALGO-NK-T-NASAL-1L- ALGO-NK-T-NASAL-1LALGO-PCNSL-2L- ALGO-PCNSL-2LALGO-PDAC-LAPC- ALGO-PDAC-LAPCALGO-PDAC-METASTATIC-1L- ALGO-PDAC-METASTATIC-1LALGO-PDAC-METASTATIC-2L- ALGO-PDAC-METASTATIC-2LALGO-PDAC-RESECTABLE-PERIOP- ALGO-PDAC-RESECTABLE-PERIOPALGO-PMBCL-2L- ALGO-PMBCL-2LALGO-PNET-METASTATIC-1L- ALGO-PNET-METASTATIC-1LALGO-PROSTATE-MHSPC-1L- ALGO-PROSTATE-MHSPC-1LALGO-RCC-METASTATIC-1L- ALGO-RCC-METASTATIC-1LALGO-SCLC-2L- ALGO-SCLC-2LALGO-THYROID-ANAPLASTIC-1L- ALGO-THYROID-ANAPLASTIC-1L